Current Evidence on the Use of Antifilarial Agents in the Management of Bancroftian Filariasis
Author Information
Author(s): Fernando Sumadhya Deepika, Rodrigo Chaturaka, Rajapakse Senaka
Primary Institution: University of Colombo, Colombo, Sri Lanka
Conclusion
The review summarizes the efficacy of various antifilarial agents in treating bancroftian filariasis, highlighting the effectiveness of diethylcarbamazine and combination therapies.
Supporting Evidence
- Diethylcarbamazine (DEC) is the main drug used for treating bancroftian filariasis.
- Ivermectin is effective but has limited macrofilaricidal effects.
- Combination therapies show better long-term outcomes than single drug treatments.
- Doxycycline can reduce microfilaria rates and adult worm activity.
Takeaway
This study looks at different medicines used to treat a disease caused by tiny worms in the body, showing which ones work best.
Methodology
The authors conducted a MEDLINE search for articles on Wuchereria bancrofti published in English from 1999 to 2009, reviewing 73 relevant papers.
Limitations
The review was limited to articles published in English within a specific time frame, potentially missing important studies in other languages.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website